Overland Park, KS, United States of America

Dennis L Hendrickson


Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 225(Granted Patents)


Company Filing History:


Years Active: 1994-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Dennis L Hendrickson

Introduction

Dennis L Hendrickson is an accomplished inventor based in Overland Park, Kansas, United States. With a remarkable portfolio of three patents, he has made significant strides in the field of pharmaceutical formulations. His dedication to innovation and improvement in medication delivery systems sets him apart in the arena of invention.

Latest Patents

Among his notable contributions, Dennis has developed two patents for a diltiazem formulation that is suitable for once-a-day administration. This innovative formulation features a unique blend of diltiazem beads, which possess two differing dissolution profiles. This advancement is aimed at enhancing the therapeutic efficacy and patient compliance in the management of cardiovascular conditions.

Career Highlights

Dennis currently contributes his expertise at Carderm Capital L.P., where his work focuses on developing innovative healthcare solutions. His expansive knowledge in pharmacology and drug formulation has played a crucial role in the advancement of new treatment methodologies. Over the years, he has demonstrated a strong commitment to improving healthcare outcomes through scientific exploration and innovation.

Collaborations

Throughout his career, Dennis has collaborated with fellow inventors and professionals in the field, including colleagues like Dan C Dimmitt and Mark S Williams. These partnerships have enriched his work and fostered a collaborative environment that promotes the exchange of ideas, leading to enhanced inventions.

Conclusion

Dennis L Hendrickson stands out as a significant figure in the field of medicine through his innovative contributions to diltiazem formulations. His commitment to enhancing drug delivery methods not only highlights his ingenuity but also emphasizes the ongoing need for advancements in pharmaceutical science. As he continues his work at Carderm Capital L.P., he remains a valuable asset to the field of innovation and an inspiration for aspiring inventors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…